Jazz Pharmaceuticals
JAZZ
#2103
Rank
C$10.50 B
Marketcap
$173.78
Share price
4.52%
Change (1 day)
4.95%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.97

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.97. In 2022 the company made an earnings per share (EPS) of -$4.94 an increase over its 2021 EPS that were of -$7.50.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.97-60.01%
2022-$4.94-34.2%
2021-$7.50-224.83%
2020$6.01-53.25%
2019$12.8623.59%
2018$10.40-8.24%
2017$11.3423.74%
2016$9.1622.12%
2015$7.50478.49%
2014$1.30-74.93%
2013$5.17-27.11%
2012$7.1069.1%
2011$4.20245.98%
2010$1.21-462.5%
2009-$0.33-96.7%
2008-$10.15-27.04%
2007-$13.9165.47%
2006-$8.41-4.59%
2005-$8.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.61 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.56-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.21-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.79 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel